These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3067156)

  • 1. A role for biogenic amines in developmental language disorders.
    Kerbeshian J; Gascon G; Burd L
    Neurosci Biobehav Rev; 1988; 12(3-4):289-93. PubMed ID: 3067156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A treatable language disorder: pharmacological treatment of pervasive developmental disorder.
    Fisher W; Kerbeshian J; Burd L
    J Dev Behav Pediatr; 1986 Apr; 7(2):73-6. PubMed ID: 3700663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 4. [Huntington's disease: molecular foundations and implications in the characterisation of the neuronal mechanisms responsible for linguistic processing].
    Benítez-Burraco A
    Rev Neurol; 2009 Jan 16-31; 48(2):75-84. PubMed ID: 19173205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of biogenic amines in the central nervous system.
    Goldstein M
    Psychopharmacol Bull; 1975 Jul; 11(3):61. PubMed ID: 807931
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent developments in Parkinson's disease and Huntington's chorea.
    Barbeau A
    Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nickel on the levels of dopamine, noradrenaline and serotonin in different regions of the rat brain.
    Fatehyab S; Hasan M; Hasan MZ; Anwar J
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):318-20. PubMed ID: 7468231
    [No Abstract]   [Full Text] [Related]  

  • 8. Language and Parkinson's disease.
    Bastiaanse R; Leenders KL
    Cortex; 2009 Sep; 45(8):912-4. PubMed ID: 19447385
    [No Abstract]   [Full Text] [Related]  

  • 9. Tourette's medications: effect on minor oxidative and reductive pathways of biogenic amines.
    Messiha FS
    Neurosci Biobehav Rev; 1988; 12(3-4):215-8. PubMed ID: 3226645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical pharmacology of Gilles de la Tourette's syndrome.
    Messiha FS
    Neurosci Biobehav Rev; 1988; 12(3-4):295-305. PubMed ID: 3067157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular actions of biogenic amines.
    Blenau W
    Arch Insect Biochem Physiol; 2005 Jul; 59(3):99-102. PubMed ID: 15986381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Several results and prospects for studies of the basal ganglia].
    Cherkes VO
    Fiziol Zh; 1976; 22(1):117-26. PubMed ID: 176066
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurochemistry and defects of biogenic amine neurotransmitter metabolism.
    Hyland K
    J Inherit Metab Dis; 1999 Jun; 22(4):353-63. PubMed ID: 10407772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses.
    Issa F; Gerhardt GA; Bartko JJ; Suddath RL; Lynch M; Gamache PH; Freedman R; Wyatt RJ; Kirch DG
    Psychiatry Res; 1994 Jun; 52(3):237-49. PubMed ID: 7991718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoamine oxidase activity and the content of biogenic amines in the brain under the action of haloperidol].
    Dovedova EL
    Nerv Sist; 1991; 30():134-40. PubMed ID: 1817229
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.
    Potter WZ
    Drugs; 1984 Aug; 28(2):127-43. PubMed ID: 6205841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism for formation and maintenance of synapses by biogenic amines].
    Okado N
    Tanpakushitsu Kakusan Koso; 2000 Feb; 45(3 Suppl):294-300. PubMed ID: 10707633
    [No Abstract]   [Full Text] [Related]  

  • 18. Trace amines and mental disorders.
    Boulton AA
    Can J Neurol Sci; 1980 Aug; 7(3):261-3. PubMed ID: 7004611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical aspects of experimentally induced parkinsonism.
    Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.